ABNOBA India, in collaboration with ABNOBA GmbH Germany, brings innovative mistletoe-based therapies to India, offering cancer patients a holistic, integrative approach to treatment. ABNOBA GmbH, based in Pforzheim, Germany, is a research-driven pharmaceutical company dedicated to developing plant-based medicines, with a strong focus on mistletoe therapy for cancer care.
What is Mistletoe Therapy?
Mistletoe (Viscum album L.) is a semi-parasitic plant traditionally used in European medicine for over a century. In oncology, mistletoe extracts are widely recognized as one of the most researched complementary therapies. They are used alongside conventional cancer treatments such as chemotherapy, radiotherapy, or surgery to improve patient well-being and quality of life.
Benefits of Mistletoe Therapy for Cancer Patients
Clinical studies and patient experiences suggest that mistletoe extracts may offer multiple supportive benefits, including:
-
Improved Quality of Life – Patients often report reduced fatigue, better sleep, and enhanced overall vitality.
-
Strengthened Immune System – Mistletoe extracts stimulate the immune response, helping the body to fight disease.
-
Reduced Side Effects of Conventional Treatments – Many patients experience relief from nausea, loss of appetite, and fatigue caused by chemotherapy or radiotherapy.
-
Pain Reduction – Certain studies indicate mistletoe can help reduce cancer-related pain and improve tolerance to treatment.
-
Enhanced Emotional Well-being – Patients often feel more balanced, less anxious, and emotionally stronger during therapy.
How Mistletoe Works in Cancer Care
Mistletoe extracts contain biologically active compounds such as lectins and viscotoxins, which are believed to:
-
Stimulate immune cells (e.g., NK cells, T-lymphocytes).
-
Induce apoptosis (programmed cell death) in certain tumor cells.
-
Improve circulation and metabolism.
This dual action—supporting the body’s defenses and acting directly on cancer cells—makes mistletoe therapy a unique complementary treatment.
Mistletoe Therapy in Integrative Oncology
In many European countries, mistletoe therapy is an integral part of integrative oncology. It is administered subcutaneously (small injections under the skin) or, in some cases, intravenously. The dosage and treatment plan are personalized according to the patient’s condition, type of cancer, and overall health.
ABNOBA India: Bringing German Expertise to Indian Patients
ABNOBA India, in partnership with ABNOBA GmbH, ensures that Indian cancer patients can access authentic, research-backed mistletoe extracts manufactured in Germany under the highest pharmaceutical standards. The therapy is designed to support—not replace—conventional cancer treatments, offering a more holistic healing journey.
Who Can Benefit?
Mistletoe therapy may be beneficial for:
-
Patients undergoing chemotherapy or radiotherapy.
-
Patients experiencing fatigue, pain, or appetite loss due to cancer.
-
Patients seeking integrative, natural supportive therapies alongside standard treatment.
Conclusion
Mistletoe therapy represents hope for cancer patients who wish to improve their quality of life, reduce treatment side effects, and support their immune system naturally. With ABNOBA India, patients now have access to trusted mistletoe extracts backed by German research and pharmaceutical excellence.
